Current Gene Therapy


Liang Cheng
College of Bioinformatics Science and Technology
Harbin Medical University
Harbin, Heilongjiang


Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:17   Issue: 4
Pp: 259-260
Michele Simonato
DOI: 10.2174/156652321704180104153220

Editorial: CRISPR Medicine: From Bench to Bedside free to download

Volume:17   Issue: 4
Pp: 261-262
Graham Dellaire
DOI: 10.2174/156652321704180104153508

CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo

Volume:17   Issue: 4
Pp: 263-274
Jayme Salsman, Jean-Yves Masson, Alexandre Orthwein* and Graham Dellaire*
DOI: 10.2174/1566523217666171122094629

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery

Volume:17   Issue: 4
Pp: 275-285
Francis Robert, Sidong Huang and Jerry Pelletier*
DOI: 10.2174/1566523217666171121164615

New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish

Volume:17   Issue: 4
Pp: 286-300
Sergey V. Prykhozhij , Lucia Caceres and Jason N. Berman
DOI: 10.2174/1566523217666171121164132

Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy

Volume:17   Issue: 4
Pp: 301-308
Tatianna Wai Ying Wong and Ronald D. Cohn*
DOI: 10.2174/1566523217666171121165046

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready? open access plus

Volume:17   Issue: 4
Pp: 309-319
Francoise Baylis* and Marcus McLeod
DOI: 10.2174/1566523217666171121165935

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy open access plus

Volume:17   Issue: 4
Pp: 320-326
Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*
DOI: 10.2174/1566523218666171129204926